The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Abstract
Chronic kidney disease (CKD) and ESRD, treated with conventional hemo- or peritoneal dialysis are both associated with a high prevalence of an increase in left ventricular mass (left ventricular hypertrophy [LVH]), intermyocardial cell fibrosis, and capillary loss. Cardiac magnetic resonance imaging is the best way to detect and quantify these abnormalities, but M-Mode and 2-D echocardiography can also be used if one recognizes their pitfalls. The mechanisms underlying these abnormalities in CKD and ESRD are diverse but involve afterload (arterial pressure and compliance), preload (intravascular volume and anemia), and a wide variety of afterload/preload independent factors. The hemodynamic, metabolic, cellular, and molecular mediators of myocardial hypertrophy, fibrosis, apoptosis, and capillary degeneration are increasingly well understood. These abnormalities predispose to sudden cardiac death, most likely by promotion of electrical instability and re-entry arrhythmias and congestive heart failure. Current treatment modalities for CKD and ESRD, including thrice weekly conventional hemodialysis and peritoneal dialysis and metabolic and anemia management regimens, do not adequately prevent or correct these abnormalities. A new paradigm of therapy for CKD and ESRD that places prevention and reversal of LVH and cardiac fibrosis as a high priority is needed. This will require novel approaches to management and controlled interventional trials to provide evidence to fuel the transition from old to new treatment strategies. In the meantime, key management principles designed to ameliorate LVH and its complications should become a routine part of the care of the patients with CKD and ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,882
de Simone, G., Daniels, S. R., Devereux, R. B., Meyer, R. A., Roman, M. J., de Divitiis, O., & Alderman, M. H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90385-z · Cited by 1,734
Impact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
Hemodialysis-Induced Cardiac Injury: Determinants and Associated Outcomes
Burton, J. O., Jefferies, H. J., Selby, N. M., & McIntyre, C. W. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03900808 · Cited by 686
Culleton, B. F., Walsh, M., Klarenbach, S. W., Mortis, G., Scott-Douglas, N., Quinn, R. R., Tonelli, M., Donnelly, S., Friedrich, M. G., Kumar, A., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1291 · Cited by 683
Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy
Cice, G., Ferrara, L., D’Andrea, A., D’Isa, S., Di Benedetto, A., Cittadini, A., Russo, P. E., Golino, P., & Calabrò, R. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00241-9 · Cited by 537
McMullen, J. R., Sherwood, M. C., Tarnavski, O., Zhang, L., Dorfman, A. L., Shioi, T., & Izumo, S. (2004) · Circulation · doi:10.1161/01.cir.0000130641.08705.45 · Cited by 518
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release
Oberleithner, H., Riethmüller, C., Schillers, H., MacGregor, G. A., de Wardener, H. E., & Hausberg, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707791104 · Cited by 480
London, G. M., Pannier, B., Guerin, A. P., Blacher, J., Marchais, S. J., Darne, B., Metivier, F., Adda, H., & Safar, M. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122759 · Cited by 468
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
Shioi, T., McMullen, J. R., Tarnavski, O., Converso, K., Sherwood, M. C., Manning, W. J., & Izumo, S. (2003) · Circulation · doi:10.1161/01.cir.0000057979.36322.88 · Cited by 462
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Foley, R. N., Parfrey, P. S., Morgan, J., Barré, P. E., Campbell, P., Cartier, P., Coyle, D., Fine, A., Handa, P., Kingma, I., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00289.x · Cited by 412
The role of autophagy in the heart
Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J., & Otsu, K. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.163 · Cited by 393
Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121039 · Cited by 373
Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Giacone, G., Stancanelli, B., Cataliotti, A., & Malatino, L. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00530.x · Cited by 363
Gender differences and normal left ventricular anatomy in an adult population free of hypertension
Salton, C. J., Chuang, M. L., O’Donnell, C. J., Kupka, M. J., Larson, M. G., Kissinger, K. V., Edelman, R. R., Levy, D., & Manning, W. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01712-6 · Cited by 359
Bodyak, N., Ayus, J. C., Achinger, S., Shivalingappa, V., Ke, Q., Chen, Y.-S., Rigor, D. L., Stillman, I., Tamez, H., Kroeger, P. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611202104 · Cited by 333
Pewsner, D., Jüni, P., Egger, M., Battaglia, M., Sundström, J., & Bachmann, L. M. (2007) · BMJ · doi:10.1136/bmj.39276.636354.ae · Cited by 328
Outcome and risk factors of ischemic heart disease in chronic uremia
Parfrey, P. S., Foley, R. N., Harnett, J. D., Kent, G. M., Murray, D., & Barre, P. E. (1996) · Kidney International · doi:10.1038/ki.1996.201 · Cited by 325
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Dorn, G. W. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn243 · Cited by 305
Prognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis
Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122768 · Cited by 292
Diffuse Intermyocardiocytic Fibrosis in Uraemic Patients
Mall, G., Huther, W., Schneider, J., Lundin, P., & Ritz, E. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.1.39 · Cited by 285
Ayus, J. C., Mizani, M. R., Achinger, S. G., Thadhani, R., Go, A. S., & Lee, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040392 · Cited by 265
Kribben, A., Witzke, O., Hillen, U., Barkhausen, J., Daul, A. E., & Erbel, R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.061 · Cited by 264
Serial Change in Echocardiographic Parameters and Cardiac Failure in End-Stage Renal Disease
FOLEY, R. N., PARFREY, P. S., KENT, G. M., HARNETT, J. D., MURRAY, D. C., & BARRE, P. E. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v115912 · Cited by 251
Sadoshima, J., & Izumo, S. (1995) · Circulation Research · doi:10.1161/01.res.77.6.1040 · Cited by 229
Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy
Piovesan, A., Molineri, N., Casasso, F., Emmolo, I., Ugliengo, G., Cesario, F., & Borretta, G. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00651.x · Cited by 220
Left Ventricular Hypertrophy in Nondiabetic Predialysis CKD
Paoletti, E., Bellino, D., Cassottana, P., Rolla, D., & Cannella, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.031 · Cited by 219
Roger, S. D., McMahon, L. P., Clarkson, A., Disney, A., Harris, D., Hawley, C., Healy, H., Kerr, P., Lynn, K., Parnham, A., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102471.89084.8b · Cited by 216
Use of Cardiac Biomarkers in End-Stage Renal Disease
Wang, A. Y.-M., & Lai, K.-N. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010012 · Cited by 211
Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients
De Paula, F. M., Peixoto, A. J., Pinto, L. V., Dorigo, D., Patricio, P. J. M., & Santos, S. F. F. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00876.x · Cited by 206
Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000117977.14912.91 · Cited by 206
Kidney-Heart Interactions: Epidemiology, Pathogenesis, and Treatment
Berl, T., & Henrich, W. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00730805 · Cited by 201
Schunkert, H., Sadoshima, J.-I., Cornelius, T., Kagaya, Y., Weinberg, E. O., Izumo, S., Riegger, G., & Lorell, B. H. (1995) · Circulation Research · doi:10.1161/01.res.76.3.489 · Cited by 200
Levin, A., Djurdjev, O., Thompson, C., Barrett, B., Ethier, J., Carlisle, E., Barre, P., Magner, P., Muirhead, N., Tobe, S., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.007 · Cited by 196
Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients
Aoki, J., Ikari, Y., Nakajima, H., Mori, M., Sugimoto, T., Hatori, M., Tanimoto, S., Amiya, E., & Hara, K. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00086.x · Cited by 193
Frequent Hemodialysis Network (FHN) randomized trials: Study design
Suri, R. S., for the Frequent Hemodialysis Network (FHN) Trail Group, Garg, A. X., Chertow, G. M., Levin, N. W., Rocco, M. V., Greene, T., Beck, G. J., Gassman, J. J., Eggers, P. W., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002032 · Cited by 188
Adaptive response of the heart to long-term anemia induced by iron deficiency
Naito, Y., Tsujino, T., Matsumoto, M., Sakoda, T., Ohyanagi, M., & Masuyama, T. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00463.2008 · Cited by 171
Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation
Diwan, A., Wansapura, J., Syed, F. M., Matkovich, S. J., Lorenz, J. N., & Dorn, G. W. (2008) · Circulation · doi:10.1161/circulationaha.107.727073 · Cited by 168
Renin-Angiotensin System, Hypertrophy and Gene Expression in Cardiac Myocytes
Lijnen, P., & Petrov, V. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0934 · Cited by 164
Stewart, G. A., Foster, J., Cowan, M., Rooney, E., Mcdonagh, T., Dargie, H. J., Rodger, R. S. C., & Jardine, A. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00786.x · Cited by 164
Gross, M., & Ritz, E. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00454.x · Cited by 162
Jula, A., & Karanko, H. (1994) · Circulation · doi:10.1161/01.cir.89.3.1023 · Cited by 151
Kudoh, S., Komuro, I., Hiroi, Y., Zou, Y., Harada, K., Sugaya, T., Takekoshi, N., Murakami, K., Kadowaki, T., & Yazaki, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24037 · Cited by 141
The Challenge of Sudden Death in Dialysis Patients
Ritz, E., & Wanner, C. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04571007 · Cited by 122
Takeuchi, M., Nishikage, T., Mor‐Avi, V., Sugeng, L., Weinert, L., Nakai, H., Salgo, I. S., Gérard, O., & Lang, R. M. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.07.008 · Cited by 121
Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease
Marchais, S. J., Métivier, F., Guérin, A. P., & London, G. M. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.9.2178 · Cited by 118
The role of vitamin D in left ventricular hypertrophy and cardiac function
Achinger, S. G., & Ayus, J. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09506.x · Cited by 114
Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD Patients
Parfrey, P. S., Lauve, M., Latrémouille-Viau, D., & Lefèbvre, P. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02730608 · Cited by 113
Stróżecki, P., Adamowicz, A., Nartowicz, E., Odrowąż‐Sypniewska, G., Włodarczyk, Z., & Manitius, J. (2001) · Renal Failure · doi:10.1081/jdi-100001291 · Cited by 107
McMahon, L. P., Roger, S. D., & Levin, A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130566.69170.5e · Cited by 97
MacRae, J. M., Levin, A., & Belenkie, I. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00185.x · Cited by 95
Devereux, R. B., Palmieri, V., Liu, J. E., Wachtell, K., Bella, J. N., Boman, K., Gerdts, E., Nieminen, M. S., Papademetriou, V., & Dahlöf, B. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00033 · Cited by 93
Volume Control, Blood Pressure and Cardiovascular Function
Charra, B., & Chazot, C. (2003) · Nephron Physiology · doi:10.1159/000070242 · Cited by 89
Xu, X. Y., Hu, X., Lu, Z., Zhang, P., Zhao, L., Wessale, J. L., Bache, R. J., & Chen, Y. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.006 · Cited by 81
Krane, V., for the German Diabetes and Dialysis Study Investigators, Winkler, K., Drechsler, C., Lilienthal, J., März, W., & Wanner, C. (2008) · Kidney International · doi:10.1038/ki.2008.484 · Cited by 79
Zolty, R., Hynes, P., & Vittorio, T. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02407.x · Cited by 66
Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats
Koleganova, N., Piecha, G., Ritz, E., & Gross, M.-L. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn549 · Cited by 58
L-Carnitine Supplementation Decreases the Left Ventricular Mass in Patients Undergoing Hemodialysis
Sakurabayashi, T., Miyazaki, S., Yuasa, Y., Sakai, S., Suzuki, M., Takahashi, S., & Hirasawa, Y. (2008) · Circulation Journal · doi:10.1253/circj.72.926 · Cited by 56
Hsu, S., Nagayama, T., Koitabashi, N., Zhang, M., Zhou, L., Bedja, D., Gabrielson, K. L., Molkentin, J. D., Kass, D. A., & Takimoto, E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn324 · Cited by 52
Impact of Residual Renal Function on Volume Status in Chronic Renal Failure
Pecoits‐Filho, R., Gonçalves, S., Barberato, S. H., Bignelli, A. T., Lindholm, B., RIELLA, M. C., & Stenvinkel, P. (2004) · Blood Purification · doi:10.1159/000078699 · Cited by 49
Self-citationHYPERTENSION IN HEMODIALYSIS PATIENTS: Cardiac Consequences of Hypertension in Hemodialysis Patients
Zoccali, C., Benedetto, F. A., Tripepi, G. L., & Mallamaci, F. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17331.x · Cited by 44
Macdougall, I. C., Temple, R. M., Kwan, J. T. C., & on behalf of the EPO-GBR-2 Study Group (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl483 · Cited by 44
Cardiovascular Problems on Hemodialysis: Current Deficits and Potential Improvement
Ritz, E., & Bommer, J. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01960309 · Cited by 44
Steigerwalt, S. P., Zafar, A., Mesiha, N., Gardin, J. M., & Provenzano, R. (2007) · American Journal of Nephrology · doi:10.1159/000100106 · Cited by 42
Koleganova, N., Piecha, G., Ritz, E., Bekeredjian, R., Schirmacher, P., Schmitt, C. P., & Groß, M.-L. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.7 · Cited by 39
Moon, K. H., Song, I. S., Yang, W. S., Shin, Y. T., Kim, S. B., Song, J. K., & Park, J. S. (2000) · American Journal of Nephrology · doi:10.1159/000013625 · Cited by 39
Chmielewski, M. S., Carrero, J. J., Stenvinkel, P., & Lindholm, B. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32831ef234 · Cited by 34
Relationship between Parathyroid Hormone and Cardiac Abnormalities in Chronic Dialysis Patients
Fujii, H., Kim, J., Abe, T., Umezu, M., & Fukagawa, M. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0269 · Cited by 31
The Neglect of Sodium Restriction in Dialysis Patients: A Short Review
Charra, B., & Chazot, C. (2003) · Hemodialysis International · doi:10.1046/j.1492-7535.2003.00060.x · Cited by 22
Nobakhthaghighi, N., Kamgar, M., Bekheirnia, M. R., McFann, K., Estacio, R. O., & Schrier, R. W. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00750306 · Cited by 18
Cited by
Jankowski, J., Floege, J., Fliser, D., Böhm, M., & Marx, N. (2021) · Circulation · doi:10.1161/circulationaha.120.050686 · Cited by 1,904
Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality
Flythe, J. E., Kimmel, S. E., & Brunelli, S. M. (2011) · Kidney International · doi:10.1038/ki.2010.383 · Cited by 501
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
Xie, J., Cha, S.-K., An, S.-W., Kuro-o, M., Birnbaumer, L., & Huang, C.-L. (2012) · Nature Communications · doi:10.1038/ncomms2240 · Cited by 329
Xie, J., Yoon, J., An, S.-W., Kuro-o, M., & Huang, C.-L. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040325 · Cited by 263
Metadata
- Authors
- Glassock, R. J., Pecoits-Filho, R., & Barberato, S. H.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-12
- Volume
- 4
- Issue
- Supplement_1
- Pages
- S79-S91
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2151284198
- Cited by
- 352
- References
- 74
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.